Patents by Inventor Donna M. Rennick

Donna M. Rennick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAMMALIAN CYTOKINES; RELATED REAGENTS AND METHODS
    Publication number: 20140335094
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: July 14, 2014
    Publication date: November 13, 2014
    Inventors: Birgit Oppmann, Rene de Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
    Publication number: 20120141411
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: January 25, 2012
    Publication date: June 7, 2012
    Applicant: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
    Publication number: 20110223130
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: April 20, 2011
    Publication date: September 15, 2011
    Applicant: Schering Corporation
    Inventors: STEPHEN D. HURST, Sandra M. Zurawski, Donna M. Rennick
  • Mammalian Cytokines; Related Reagents and Methods
    Publication number: 20110177022
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: January 4, 2011
    Publication date: July 21, 2011
    Applicant: Schering Corporation
    Inventors: Birgit Oppmann, Rene de Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • IL-12P40 and IL-B30 polypeptide complex
    Patent number: 7883695
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: February 8, 2011
    Assignee: Schering Corporation
    Inventors: Birgit Oppmann, Rene de Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Uses of Mammalian Cytokine; Related Reagents
    Publication number: 20100143357
    Abstract: Provided are methods of treatment for inflammatory and autoimmune disorders of the central nervous system and gastrointestinal tract. Also provided are methods of diagnosis.
    Type: Application
    Filed: February 19, 2010
    Publication date: June 10, 2010
    Applicant: SCHERING CORPORATION
    Inventors: Daniel J. Cua, Yi Chen, Robert A. Kastelein, Claire L. Langrish, Donna M. Rennick, Jonathon Sedgwick
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A TH2 IMMUNE RESPONSE
    Publication number: 20100136020
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: November 6, 2009
    Publication date: June 3, 2010
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
    Publication number: 20090263401
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: December 17, 2007
    Publication date: October 22, 2009
    Applicant: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity
    Publication number: 20090092604
    Abstract: Provided are methods of treatment for inflammatory and autoimmune disorders of the central nervous system and gastrointestinal tract. Also provided are methods of diagnosis.
    Type: Application
    Filed: November 20, 2008
    Publication date: April 9, 2009
    Applicant: SCHERING CORPORATION
    Inventors: Daniel J. Cua, Yi Chen, Robert A. Kastelein, Claire L. Langrish, Donna M. Rennick, Jonathon Sedgwick
  • Uses of IL-174 for treating helminth infections
    Patent number: 7357924
    Abstract: Use of the cytokine designated IL-174 to treat infectious diseases such as helminth infections.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: April 15, 2008
    Assignee: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Mammalian genes; related reagents and methods
    Patent number: 7183382
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: February 27, 2007
    Assignee: Schering Corporation
    Inventors: Birgit Oppmann, Rene De Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Mammalian cytokines; related reagents and methods
    Patent number: 7090847
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: August 15, 2006
    Assignee: Schering Corporation
    Inventors: Birgit Oppmann, Rene De Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Uses of mammalian cytokine; related reagents
    Publication number: 20040219150
    Abstract: Provided are methods of treatment for inflammatory and autoimmune disorders of the central nervous system and gastrointestinal tract. Also provided are methods of diagnosis.
    Type: Application
    Filed: February 4, 2004
    Publication date: November 4, 2004
    Inventors: Daniel J. Cua, Yi Chen, Robert A. Kastelein, Claire L. Langrish, Donna M. Rennick, Jonathon Sedgwick
  • Cytokine uses; compositions; methods
    Publication number: 20040076608
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: November 10, 2003
    Publication date: April 22, 2004
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Methods of modulating IL-174 response
    Patent number: 6676939
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: January 13, 2004
    Assignee: Schering Corporation
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • METHODS OF MODULATING IL- 174 RESPONSE
    Publication number: 20030165460
    Abstract: Agonists or antagonists of cytokine designated IL-174, and various methods of their use are provided. In particular, the methods make use of facts that many activities of the IL-174 cytokine are described.
    Type: Application
    Filed: April 17, 2001
    Publication date: September 4, 2003
    Inventors: Stephen D. Hurst, Sandra M. Zurawski, Donna M. Rennick
  • Mammalian cytokines; related reagents and methods
    Publication number: 20030162261
    Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: February 27, 2003
    Publication date: August 28, 2003
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Birgit Oppmann, Rene De Waal Malefyt, Donna M. Rennick, Robert A. Kastelein, Maria T. Wiekowski, Sergio A. Lira, Satwant K. Narula
  • Lymphotactin uses
    Publication number: 20030007970
    Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
    Type: Application
    Filed: May 20, 2002
    Publication date: January 9, 2003
    Applicant: Schering Corporation, a New Jersey corporation
    Inventors: Joseph A. Hedrick, Susan A. Hudak, Donna M. Rennick, Albert Zlotnik
  • Lymphotactin uses
    Patent number: 6395268
    Abstract: This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
    Type: Grant
    Filed: December 8, 1999
    Date of Patent: May 28, 2002
    Assignee: Schering Corporation
    Inventors: Joseph A. Hedrick, Susan A. Hudak, Donna M. Rennick, Albert Zlotnik
  • Method of treating eosinophilia
    Patent number: 5096704
    Abstract: A method of preventing eosinophilia associated with certain immune disorders is provided. The method comprises administering an effective amount of an antagonist to human interleukin-5. Preferably, the antagonist is a blocking monoclonal antibody specific for human interleukin-5, or a fragment or binding composition derived therefrom.
    Type: Grant
    Filed: July 23, 1990
    Date of Patent: March 17, 1992
    Assignee: Schering Corporation
    Inventors: Robert L. Coffman, Donna M. Rennick